S Nakamura

Summary

Affiliation: Hayashibara Biochemical Laboratories
Country: Japan

Publications

  1. ncbi A thymus-specific noncoding RNA, Thy-ncR1, is a cytoplasmic riboregulator of MFAP4 mRNA in immature T-cell lines
    Kazuma Aoki
    Biomedicinal Information Research Center, National Institute of Advanced Industrial Science and Technology, Koutou, Tokyo, Japan
    BMC Mol Biol 11:99. 2010
  2. ncbi IFN-gamma-dependent and -independent mechanisms in adverse effects caused by concomitant administration of IL-18 and IL-12
    S Nakamura
    Fujisaki Cell Center and Fujisaki Institute, Hayashibara Biochemical Laboratories, Inc, Okayama City, Okayama, Japan
    J Immunol 164:3330-6. 2000
  3. ncbi IL-2-independent generation of FOXP3(+)CD4(+)CD8(+)CD25(+) cytotoxic regulatory T cell lines from human umbilical cord blood
    Shuji Nakamura
    Cell Biology Institute, Research Center, Hayashibara Biochemical Laboratories, Inc, Okayama, Okayama, Japan
    Exp Hematol 35:287-96. 2007
  4. ncbi Characterization of anti-human interleukin-18 (IL-18)/interferon-gamma-inducing factor (IGIF) monoclonal antibodies and their application in the measurement of human IL-18 by ELISA
    M Taniguchi
    Fujisaki Institute, Hayashibara Biochemical Laboratories Inc, Okayama, Japan
    J Immunol Methods 206:107-13. 1997
  5. ncbi Identification of a vascular endothelial growth factor (VEGF) antagonist, sFlt-1, from a human hematopoietic cell line NALM-16
    T Inoue
    Fujisaki Cell Center, Hayashibara Biochemical Laboratories, Inc, 675 1 Fujisaki, Okayama, Japan
    FEBS Lett 469:14-8. 2000
  6. ncbi Expression of tumour necrosis factor receptors by bronchoalveolar cells in hypersensitivity pneumonitis
    B Chen
    Ruhrlandklinik, Tuschener Weg 40, 45239 Essen, Germany
    Eur Respir J 25:1039-43. 2005
  7. ncbi FOXP3, a selective marker for a subset of adult T-cell leukaemia/lymphoma
    G Roncador
    Monoclonal Antibodies Unit, Biotechnology Program, Centro Nacional de Investigaciones Oncologicas CNIO, Madrid, Spain
    Leukemia 19:2247-53. 2005
  8. ncbi Biological behavior of myoepithelial cells in the regeneration of rat atrophied sublingual glands following release from duct ligation
    S Takahashi
    Department of Oral Health Science, Hokkaido University Graduate School of Dental Medicine, Sapporo, 060 8586, Japan
    J Mol Histol 36:373-9. 2005
  9. ncbi Trisomy 3 is a specific genomic aberration of t(14;18) negative follicular lymphoma
    H Tagawa
    Leukemia 21:2549-51. 2007
  10. ncbi Increase of RP105-lacking activated B cells in the peripheral blood and salivary glands in patients with Sjögren's syndrome
    Y Kikuchi
    Department of Internal Medicine, Faculty of Medicine, Saga University, Japan
    Clin Exp Rheumatol 26:5-12. 2008

Collaborators

Detail Information

Publications20

  1. ncbi A thymus-specific noncoding RNA, Thy-ncR1, is a cytoplasmic riboregulator of MFAP4 mRNA in immature T-cell lines
    Kazuma Aoki
    Biomedicinal Information Research Center, National Institute of Advanced Industrial Science and Technology, Koutou, Tokyo, Japan
    BMC Mol Biol 11:99. 2010
    ..We investigated the characteristics and function of ncRNAs that were specifically expressed in the thymus, the site of T-cell selection and maturation...
  2. ncbi IFN-gamma-dependent and -independent mechanisms in adverse effects caused by concomitant administration of IL-18 and IL-12
    S Nakamura
    Fujisaki Cell Center and Fujisaki Institute, Hayashibara Biochemical Laboratories, Inc, Okayama City, Okayama, Japan
    J Immunol 164:3330-6. 2000
    ..These results indicate that IL-18/IL-12 treatment induces severe adverse effects through not only IFN-gamma-dependent mechanisms but also IFN-gamma-independent processes...
  3. ncbi IL-2-independent generation of FOXP3(+)CD4(+)CD8(+)CD25(+) cytotoxic regulatory T cell lines from human umbilical cord blood
    Shuji Nakamura
    Cell Biology Institute, Research Center, Hayashibara Biochemical Laboratories, Inc, Okayama, Okayama, Japan
    Exp Hematol 35:287-96. 2007
    ..Here we show the establishment of novel Treg cell lines possessing unique characteristics...
  4. ncbi Characterization of anti-human interleukin-18 (IL-18)/interferon-gamma-inducing factor (IGIF) monoclonal antibodies and their application in the measurement of human IL-18 by ELISA
    M Taniguchi
    Fujisaki Institute, Hayashibara Biochemical Laboratories Inc, Okayama, Japan
    J Immunol Methods 206:107-13. 1997
    ..This ELISA would become a powerful tool for investigating the relationship between IL-18 and various diseases or analyzing the control mechanisms of IL-18 production from IL-18 producing cells...
  5. ncbi Identification of a vascular endothelial growth factor (VEGF) antagonist, sFlt-1, from a human hematopoietic cell line NALM-16
    T Inoue
    Fujisaki Cell Center, Hayashibara Biochemical Laboratories, Inc, 675 1 Fujisaki, Okayama, Japan
    FEBS Lett 469:14-8. 2000
    ....
  6. ncbi Expression of tumour necrosis factor receptors by bronchoalveolar cells in hypersensitivity pneumonitis
    B Chen
    Ruhrlandklinik, Tuschener Weg 40, 45239 Essen, Germany
    Eur Respir J 25:1039-43. 2005
    ..In conclusion, this study shows evidence of altered expression of tumour necrosis factor superfamily receptors in hypersensitivity pneumonitis...
  7. ncbi FOXP3, a selective marker for a subset of adult T-cell leukaemia/lymphoma
    G Roncador
    Monoclonal Antibodies Unit, Biotechnology Program, Centro Nacional de Investigaciones Oncologicas CNIO, Madrid, Spain
    Leukemia 19:2247-53. 2005
    ..No other lymphoma types studied exhibited FOXP3 expression in the malignant population. The selective expression of FOXP3 by tumour cells in ATLL makes this antibody a potentially useful diagnostic tool...
  8. ncbi Biological behavior of myoepithelial cells in the regeneration of rat atrophied sublingual glands following release from duct ligation
    S Takahashi
    Department of Oral Health Science, Hokkaido University Graduate School of Dental Medicine, Sapporo, 060 8586, Japan
    J Mol Histol 36:373-9. 2005
    ....
  9. ncbi Trisomy 3 is a specific genomic aberration of t(14;18) negative follicular lymphoma
    H Tagawa
    Leukemia 21:2549-51. 2007
  10. ncbi Increase of RP105-lacking activated B cells in the peripheral blood and salivary glands in patients with Sjögren's syndrome
    Y Kikuchi
    Department of Internal Medicine, Faculty of Medicine, Saga University, Japan
    Clin Exp Rheumatol 26:5-12. 2008
    ..To quantify the activated B cells in the peripheral blood and salivary glands of patients with Sjögren's syndrome (SS) by analyzing the expression of RP105 molecule on the B cells...
  11. ncbi Ileocolonic lymphomas: a series of 16 cases
    T Saito
    Second Department of Internal Medicine, Mie University School of Medicine, Tsu, Japan
    Endoscopy 37:466-9. 2005
    ..Histological and immunohistochemical investigation including that of cyclin D1 and CD5 expression is essential to make the final diagnosis...
  12. ncbi Pathology review for paediatric non-Hodgkin's lymphoma patients in Japan; a report from the Japan association of childhood leukaemia study (JACLS)
    A Nakagawa
    Department of Pathology, Aichi Medical University, Nagakute, Aichi 480 1195, Japan
    Eur J Cancer 40:725-33. 2004
    ..Through the two-step review system, highly reliable data were generated to support this study...
  13. ncbi Aggressive natural killer-cell leukemia revisited: large granular lymphocyte leukemia of cytotoxic NK cells
    R Suzuki
    Division of Molecular Medicine, Aichi Cancer Center, Nagoya, Japan
    Leukemia 18:763-70. 2004
    ..005). These findings suggest that ANKL is an entity of mature cytotoxic NK-cell neoplasms with distinct phenotype and disease presentations. Intensive treatment for ANKL may result in a better prognosis...
  14. ncbi Serum levels of the nm23-H1 protein and their clinical implication in extranodal NK/T-cell lymphoma
    N Niitsu
    Leukemia 17:987-90. 2003
  15. ncbi Morphological spectrum of cyclin D1-positive mantle cell lymphoma: study of 168 cases
    Y Yatabe
    Department of Pathology and Clinical Laboratories, Aichi Cancer Center Hospital, Nagoya, Japan
    Pathol Int 51:747-61. 2001
    ..MCL can be diagnosed with the application of cyclin D1 immunostaining, if careful attention is given to architectural and cytological features...
  16. ncbi Pregnancy-associated cytotoxic lymphoma: a report of 4 cases
    M Kato
    Second Department of Internal Medicine, Nagoya City University Medical School, Japan
    Int J Hematol 74:186-92. 2001
    ..Maternal immunity and hormonal changes during pregnancy may be closely related to the biological behavior of these unusual tumors.This study is, to the best of our knowledge, the first to address pregnancy-associated cytotoxic lymphoma...
  17. ncbi Establishment of a follicular lymphoma cell line (FLK-1) dependent on follicular dendritic cell-like cell line HK
    Y Kagami
    Department of Hematology and Chemotherapy, Aichi Cancer Center Hospital, Nagoya, Japan
    Leukemia 15:148-56. 2001
    ..The FLK-1 cell line may thus prove to be useful for studying the growth mechanism of follicular lymphoma and provide new insights into the pathogenesis of follicular lymphoma...
  18. ncbi Protein-tyrosine kinase Pyk2 is involved in interleukin-2 production by Jurkat T cells via its tyrosine 402
    T Katagiri
    Division of Biochemistry and Cellular Biology, National Institute of Neuroscience, Kodaira, Tokyo 187 8502, Japan
    J Biol Chem 275:19645-52. 2000
    ..Furthermore, we found that Pyk2, when overexpressed, associates with Zap70 and Vav. Taken together, these findings suggest that Pyk2 is involved in the activation of T cells through its tyrosine 402...
  19. ncbi Human gene encoding CD38 (ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase): organization, nucleotide sequence and alternative splicing
    K Nata
    Department of Biochemistry, Tohoku University School of Medicine, Miyagi, Japan
    Gene 186:285-92. 1997
    ..1995) Gene 158, 213-218]. This structural conservation between human and Aplysia genes suggests that both genes may have evolved from a common ancestral gene...
  20. ncbi A new mouse lymphocyte alloantigen (Ly-28) defined by monoclonal antibodies
    N Tada
    Immunogenetics 24:275-7. 1986